These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1557 related items for PubMed ID: 12420213
1. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases. Greider C, Chattopadhyay A, Parkhurst C, Yang E. Oncogene; 2002 Nov 07; 21(51):7765-75. PubMed ID: 12420213 [Abstract] [Full Text] [Related]
2. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc. Benaud CM, Dickson RB. Oncogene; 2001 Jul 27; 20(33):4554-67. PubMed ID: 11494151 [Abstract] [Full Text] [Related]
3. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR. Nature; 1997 May 22; 387(6631):422-6. PubMed ID: 9163430 [Abstract] [Full Text] [Related]
4. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). Perez-Roger I, Kim SH, Griffiths B, Sewing A, Land H. EMBO J; 1999 Oct 01; 18(19):5310-20. PubMed ID: 10508164 [Abstract] [Full Text] [Related]
5. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases. Alexandrow MG, Moses HL. J Cell Biochem; 1998 Sep 15; 70(4):528-42. PubMed ID: 9712150 [Abstract] [Full Text] [Related]
6. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation. Braun K, Hölzl G, Soucek T, Geisen C, Möröy T, Hengstschläger M. Oncogene; 1998 Oct 29; 17(17):2259-69. PubMed ID: 9811456 [Abstract] [Full Text] [Related]
7. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes. Jaumot M, Estanyol JM, Serratosa J, Agell N, Bachs O. Hepatology; 1999 Feb 29; 29(2):385-95. PubMed ID: 9918914 [Abstract] [Full Text] [Related]
8. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B. EMBO J; 1996 Dec 02; 15(23):6595-604. PubMed ID: 8978686 [Abstract] [Full Text] [Related]
9. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS. Exp Cell Res; 2000 Aug 25; 259(1):35-53. PubMed ID: 10942577 [Abstract] [Full Text] [Related]
10. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells. Mann DJ, Higgins T, Jones NC, Rozengurt E. Oncogene; 1997 Apr 17; 14(15):1759-66. PubMed ID: 9150381 [Abstract] [Full Text] [Related]
11. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. Iwanaga R, Ohtani K, Hayashi T, Nakamura M. Oncogene; 2001 Apr 19; 20(17):2055-67. PubMed ID: 11360190 [Abstract] [Full Text] [Related]
12. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL, Buffolino P, Kopman C, Nathanson L. Exp Cell Res; 1995 Nov 19; 221(1):92-102. PubMed ID: 7589260 [Abstract] [Full Text] [Related]
13. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. Bouchard C, Thieke K, Maier A, Saffrich R, Hanley-Hyde J, Ansorge W, Reed S, Sicinski P, Bartek J, Eilers M. EMBO J; 1999 Oct 01; 18(19):5321-33. PubMed ID: 10508165 [Abstract] [Full Text] [Related]
14. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Nahum A, Hirsch K, Danilenko M, Watts CK, Prall OW, Levy J, Sharoni Y. Oncogene; 2001 Jun 07; 20(26):3428-36. PubMed ID: 11423993 [Abstract] [Full Text] [Related]
15. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. Liang YC, Lin-Shiau SY, Chen CF, Lin JK. J Cell Biochem; 1999 Oct 01; 75(1):1-12. PubMed ID: 10462699 [Abstract] [Full Text] [Related]
16. Formation of p27-CDK complexes during the human mitotic cell cycle. Soos TJ, Kiyokawa H, Yan JS, Rubin MS, Giordano A, DeBlasio A, Bottega S, Wong B, Mendelsohn J, Koff A. Cell Growth Differ; 1996 Feb 01; 7(2):135-46. PubMed ID: 8822197 [Abstract] [Full Text] [Related]
17. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes. Ravanko K, Järvinen K, Paasinen-Sohns A, Hölttä E. Cancer Res; 2000 Sep 15; 60(18):5244-53. PubMed ID: 11016654 [Abstract] [Full Text] [Related]
19. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex. Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM. Exp Cell Res; 1999 Feb 25; 247(1):189-99. PubMed ID: 10047461 [Abstract] [Full Text] [Related]